CD8A and lymphoma: Additionally, significant expansion in both OVA-specific and total antigen–experienced CD8+ TILs was observed in mice bearing EG7-OVA lymphomas after DP treatment, with significant increase of both TIM-3–PD-1+ and TIM-3+PD-1+ cells (Supplemental Figure 7, A–D).